All In MedTech

FDA Clearance Tracker · P200049-S009

Amplatzer Amulet Left Atrial Appendage Occluder

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 22, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 22, 2025

Approved

Time to decision

138 days

Received Dec 5, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P200049-S009
Device name
Amplatzer Amulet Left Atrial Appendage Occluder
Applicant location
St. Paul, MN
Received
Dec 5, 2024
Decided
Apr 22, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P200049

Device type

Device class
Class III

Every decision under product code NGV

FDA's approval statement

As written in FDA's record.

approval for modifications to the Instructions for Use to reflect the findings of the final Post-Approval Study (PAS) Report submitted for the Continued Follow-up of the Amulet IDE Cohort

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.